SEER Stat Fact Sheets: Hodgkin Lymphoma
Statistics at a GlanceShow More
At a Glance
- Estimated New Cases in 2013 9,290
- Estimated Deaths in 2013 1,180
Lifetime Risk: Lifetime risk is the probability of developing or dying from a disease in the course of one's lifespan. Based on the most recent data, approximately 0.2 percent of men and women will be diagnosed with Hodgkin lymphoma at some point during their lifetime.
Prevalence of this cancer: There are an estimated 181,928 people currently living with Hodgkin lymphoma in the United States.
Survival StatisticsShow More
How Many People Survive 5 Years Or More after Being Diagnosed with Hodgkin Lymphoma?
Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2003-2009. Gray figures represent those who have died from Hodgkin lymphoma. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. For Hodgkin lymphoma, 17.2% are diagnosed at the local stage. The 5-year survival for localized Hodgkin lymphoma is 90.2%.
- Localized (17%)
Confined to Primary Site
- Regional (40%)
Spread to Regional Lymph Nodes
- Distant (38%)
Cancer Has Metastasized
- Unknown (5%)
SEER 18 2003-2009, All Races, Both Sexes by SEER Summary Stage 2000
Number of New Cases and DeathsShow More
How Common Is This Cancer?
Compared to other cancers, Hodgkin lymphoma is rare.
|Common Types of Cancer||Estimated New
|3.||Lung and Bronchus Cancer||228,190||159,480|
|4.||Colon and Rectum Cancer||142,820||50,830|
|5.||Melanoma of the Skin||76,690||9,480|
|8.||Kidney and Renal Pelvis Cancer||65,150||13,680|
Hodgkin lymphoma represents 0.6% of all new cancer cases in the U.S.
In 2013, it is estimated that there will be 9,290 new cases of Hodgkin lymphoma and an estimated 1,180 people will die of this disease.
Who Gets This Cancer?
Hodgkin lymphoma is more common among young adults and among men than women. It can occur in both adults and children; however, treatment for adults may be different than treatment for children. Hodgkin lymphoma may also occur in patients who have acquired immunodeficiency syndrome (AIDS); these patients require special treatment.
Hodgkin lymphoma rates are highest in people aged 20-34 years.
SEER 18 2006-2010, All Races, Both Sexes
- All Races
- Asian /
- Not Shown, <16 casesAmerican Indian /
SEER 18 2006-2010, Age-Adjusted
Who Dies From This Cancer?
Hodgkin lymphoma deaths are highest in people aged 75-84 years.
U.S. 2006-2010, All Races, Both Sexes
- All Races
- Asian /
- Not Shown, <16 casesAmerican Indian /
Alaska NativeNot Shown, <16 cases
U.S. 2006-2010, Age-Adjusted
Trends in RatesShow More
Changes Over Time
Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, rates for new Hodgkin lymphoma cases have been stable over the last 10 years. Death rates have been falling on average 2.2% each year over the same period. 5-year survival trends are shown below the figure.
|5-Year Relative Survival||69.8%||73.4%||78.6%||79.8%||79.6%||87.2%||85.2%||88.3%|
SEER 9 Incidence & U.S. Mortality 1975-2010, All Races, Both Sexes
More About This CancerShow More
Hodgkin lymphoma is a cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin disease.
Here are some resources for learning more about Hodgkin lymphoma.
- More about risk factors for Hodgkin lymphoma cancer
- More about symptoms and diagnosis of Hodgkin lymphoma cancer
- More about treatment options for Hodgkin lymphoma cancer
- More about clinical trials
- More about cancer prevention
All statistics in this report are based on statistics from SEER and the Centers for Disease Control's National Center for Health Statistics. Most can be found within:
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Statistics Factsheets: Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/hodg.html
This factsheet focuses on population statistics that are based on the US population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in this factsheet are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.
Cancer is a complex topic. There is a wide range of information available. This factsheet does not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although it provides links to information in many of these areas.